These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 24035828)
1. Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion. Lu A; Suofu Y; Guan F; Broderick JP; Wagner KR; Clark JF Neuroscience; 2013 Dec; 253():361-7. PubMed ID: 24035828 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion. Suofu Y; Clark JF; Broderick JP; Kurosawa Y; Wagner KR; Lu A Neuroscience; 2012 Jun; 212():180-9. PubMed ID: 22521821 [TBL] [Abstract][Full Text] [Related]
3. Ulinastatin protects brain against cerebral ischemia/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice. Li XF; Zhang XJ; Zhang C; Wang LN; Li YR; Zhang Y; He TT; Zhu XY; Cui LL; Gao BL Exp Neurol; 2018 Apr; 302():68-74. PubMed ID: 29291404 [TBL] [Abstract][Full Text] [Related]
4. Evidence that enolase-phosphatase 1 exacerbates early cerebral ischemia injury and blood-brain barrier breakdown by enhancing extracellular matrix destruction and inhibiting the interaction between ADI1 and MT1-MMP. Yang D; Su L; Li X; Xie C; Zhang Y Exp Neurol; 2023 Jul; 365():114410. PubMed ID: 37075968 [TBL] [Abstract][Full Text] [Related]
5. Selective knockout of astrocytic Na Begum G; Song S; Wang S; Zhao H; Bhuiyan MIH; Li E; Nepomuceno R; Ye Q; Sun M; Calderon MJ; Stolz DB; St Croix C; Watkins SC; Chen Y; He P; Shull GE; Sun D Glia; 2018 Jan; 66(1):126-144. PubMed ID: 28925083 [TBL] [Abstract][Full Text] [Related]
6. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats. Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. Yang Y; Estrada EY; Thompson JF; Liu W; Rosenberg GA J Cereb Blood Flow Metab; 2007 Apr; 27(4):697-709. PubMed ID: 16850029 [TBL] [Abstract][Full Text] [Related]
8. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Tu XK; Yang WZ; Liang RS; Shi SS; Chen JP; Chen CM; Wang CH; Xie HS; Chen Y; Ouyang LQ Neurochem Res; 2011 Nov; 36(11):2022-8. PubMed ID: 21678122 [TBL] [Abstract][Full Text] [Related]
9. The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia/reperfusion. Liu Y; Wang D; Wang H; Qu Y; Xiao X; Zhu Y Brain Res; 2014 Jan; 1544():45-53. PubMed ID: 24316243 [TBL] [Abstract][Full Text] [Related]
10. Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke. Yang C; Yang Y; DeMars KM; Rosenberg GA; Candelario-Jalil E Front Neurol; 2020; 11():887. PubMed ID: 32973660 [TBL] [Abstract][Full Text] [Related]
11. Tetramethylpyrazine-2'-O-sodium ferulate attenuates blood-brain barrier disruption and brain oedema after cerebral ischemia/reperfusion. Xu SH; Yin MS; Liu B; Chen ML; He GW; Zhou PP; Cui YJ; Yang D; Wu YL Hum Exp Toxicol; 2017 Jul; 36(7):670-680. PubMed ID: 27387348 [TBL] [Abstract][Full Text] [Related]
12. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia. Chen F; Wang W; Ding H; Yang Q; Dong Q; Cui M J Neuroinflammation; 2016 Aug; 13(1):204. PubMed ID: 27566245 [TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835 [TBL] [Abstract][Full Text] [Related]
14. Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. Koistinaho M; Malm TM; Kettunen MI; Goldsteins G; Starckx S; Kauppinen RA; Opdenakker G; Koistinaho J J Cereb Blood Flow Metab; 2005 Apr; 25(4):460-7. PubMed ID: 15674236 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E deficiency exacerbates blood-brain barrier disruption and hyperglycemia-associated hemorrhagic transformation after ischemic stroke. Leng C; Lin K; Zhou M; Tao X; Sun B; Shu X; Liu W J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107987. PubMed ID: 39218418 [TBL] [Abstract][Full Text] [Related]
16. Retigabine protects the blood-brain barrier by regulating tight junctions between cerebral vascular endothelial cells in cerebral ischemia-reperfusion rats. Zhao YJ; Nai Y; Li SY; Zheng YH Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8509-8518. PubMed ID: 30556894 [TBL] [Abstract][Full Text] [Related]
17. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase. Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717 [TBL] [Abstract][Full Text] [Related]
18. Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription. Sarami Foroshani M; Sobhani ZS; Mohammadi MT; Aryafar M J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3053-3065. PubMed ID: 30093209 [TBL] [Abstract][Full Text] [Related]
19. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model. Wang L; Lu Y; Zhang X; Zhang Y; Jiang D; Dong X; Deng S; Yang L; Guan Y; Zhu L; Zhou Y; Zhang X; Li H Exp Neurol; 2013 Sep; 247():506-16. PubMed ID: 23360804 [TBL] [Abstract][Full Text] [Related]